Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 31:16:1459.
doi: 10.3332/ecancer.2022.1459. eCollection 2022.

A rare case of clear cell sarcoma of the foot with a cascade of pathological misdiagnosis-the importance of expert sarcoma pathology

Affiliations

A rare case of clear cell sarcoma of the foot with a cascade of pathological misdiagnosis-the importance of expert sarcoma pathology

Anand Rajendran et al. Ecancermedicalscience. .

Abstract

Sarcoma pathology discrepancy is well known owing to the extremely heterogenous and rare nature of this tumour. Through this case, we want to highlight the difficulty that a patient has to undergo in a case of misdiagnosis. A 20-year-old male presented with swelling in the right foot for 4 months, which was initially diagnosed as alveolar rhabdomyosarcoma, subsequently as synovial sarcoma and finally as Ewing's sarcoma (based upon positive Ewing Sarcoma Breakpoint Region 1 (EWSR1) by fluorescence in situ hybridisation and he underwent neoadjuvant chemotherapy and surgical excision with grafting before he presented to our institute, where the pathologists reviewed the biopsy slides, which were positive for HMB45 and negative for Melan-A suggestive of clear cell sarcoma. The next-generation sequencing suggested EWSR1-ATF1 fusion, which again reinforced the diagnosis. This case throws light on the importance of expert pathology and interpreting molecular results in the right context.

Keywords: EWSR1; clear cell sarcoma; diagnostic discrepancy; misdiagnosis; sarcoma.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest.

Figures

Figure 1.
Figure 1.. Photograph of the swelling on the plantar aspect of right foot, taken before chemotherapy, 3 months after the onset.
Figure 2.
Figure 2.. MRI image of right foot (T1W post contrast). Lobulated soft tissue mass with poorly defined margins in the lateral plantar aspect of right foot measuring approx. 4.5 × 7.5 × 3.8 cm (CC × AP × TR). Non- enhancing regions likely representing cystic/necrotic changes. Insinuating between the 4th and 5th metatarsals and involving the intrinsic muscles and abutting the lateral aspect of flexor digitorum longus/brevis muscles and tendons. Also involving the subcutaneous tissue on the plantar aspect of the foot. No definite evidence of signal abnormality or destructive changes in the bones.
Figure 3.
Figure 3.. Cell showing two green-orange (fusion) signals indicating negative for SYT gene rearrangement. Test method: FISH. Probe description: Vysis LSI EWSR1 (22q12) Break Apart Rearrangement Probe (CE).
Figure 4.
Figure 4.. Cell showing one green-orange (yellow) fusion, one orange signal and one green signal, indicating positive for rearrangement of the EWSR1 gene. Test method: FISH. Probe description: Vysis LSI EWSR1 (22q12) Break Apart Rearrangement Probe (CE).
Figure 5.
Figure 5.. Histopathology photomicrograph of the tumour showing oval to spindle shaped cells arranged in nests as well as syncytial pattern. The tumour cells showed moderate pleomorphism with vesicular chromatin and prominent nucleoli with moderate to abundant cytoplasm with epithelioid morphology at places. (H&E 200×).
Figure 6.
Figure 6.. Immunohistochemistry for HMB45 showing diffuse cytoplasmic positivity in the tumour cells.

Similar articles

References

    1. Lauer S, Gardner JM. Soft tissue sarcomas-new approaches to diagnosis and classification. Curr Probl Cancer. 2013;37:45–61. doi: 10.1016/j.currproblcancer.2013.03.001. - DOI - PubMed
    1. Thway K, Fisher C. Histopathological diagnostic discrepancies in soft tissue tumours referred to a specialist centre. Sarcoma. 2009;2009:741975. doi: 10.1155/2009/741975. - DOI - PMC - PubMed
    1. Presant CA, Russell WO, Alexander RW, et al. Soft-tissue and bone sarcoma histopathology peer review: the frequency of disagreement in diagnosis and the need for second pathology opinions. The southeastern cancer study group experience. J Clin Oncol. 1986;4:1658–1661. doi: 10.1200/JCO.1986.4.11.1658. - DOI - PubMed
    1. Harris M, Hartley AL, Blair V, et al. Sarcomas in North West England: I. Histopathological peer review. Br J Cancer. 1991;64:315–320. doi: 10.1038/bjc.1991.298. - DOI - PMC - PubMed
    1. Arbiser ZK, Folpe AL, Weiss SW. Consultative (expert) second opinions in soft tissue pathology. Analysis of problem-prone diagnostic situations. Am J Clin Pathol. 2001;116:473–476. doi: 10.1309/425H-NW4W-XC9A-005H. - DOI - PubMed

LinkOut - more resources